Literature DB >> 3281628

Familial aggregation of schizophrenia and schizophrenia spectrum disorders. Evaluation of conflicting results.

K S Kendler1.   

Abstract

In this issue, Coryell and Zimmerman report no significant increase in the risk of schizophrenia or "schizophrenia spectrum" personality disorders in relatives of schizophrenics vs never-ill controls. This article attempts to evaluate critically and interpret their findings. Given the modest number of relatives studied, their negative findings regarding schizophrenia could easily be the result of sampling variation. Relatives were assessed using a general personality disorder instrument, and over two thirds were interviewed by telephone; this method may have a low sensitivity to detect key features of the schizophrenia spectrum such as inadequate rapport and suspiciousness. True population differences may, however, exist in the pattern of familial aggregation for schizophrenia and related disorders. The convincing demonstration of this would be of considerable interest and should lead to a constructive search for the source of the interpopulation differences.

Entities:  

Mesh:

Year:  1988        PMID: 3281628     DOI: 10.1001/archpsyc.1988.01800280095013

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  10 in total

1.  PERSONALITY FEATURES AND DISORDER IN THE SUBJECTS IN THE NEW YORK HIGH-RISK PROJECT.

Authors:  Elizabeth Squires-Wheeler; Andrew E Skodol; Ulla Hilldoff Adamo; Anne S Bassett; George R Gewirtz; William G Honer; Barbara A Cornblatt; Simone A Roberts; L Erlenmeyer-Kimling
Journal:  J Psychiatr Res       Date:  1993       Impact factor: 4.791

2.  The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal; Paul J Silvia
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

Review 3.  [The concept of schizoidia in psychiatry : From schizoidia to schizotypy and cluster A personality disorders].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2017-07-11

4.  Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter.

Authors:  C C Dickey; R W McCarley; M M Voglmaier; M A Niznikiewicz; L J Seidman; Y Hirayasu; I Fischer; E K Teh; R Van Rhoads; M Jakab; R Kikinis; F A Jolesz; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-06-01       Impact factor: 13.382

5.  DSM-III-R schizotypal personality traits in offspring of schizophrenic disorder, affective disorder, and normal control parents.

Authors:  E Squires-Wheeler; A E Skodol; A Bassett; L Erlenmeyer-Kimling
Journal:  J Psychiatr Res       Date:  1989       Impact factor: 4.791

6.  A pilot Swedish twin study of affective illness including hospital- and population-ascertained subsamples: results of model fitting.

Authors:  K S Kendler; N L Pedersen; M C Neale; A A Mathé
Journal:  Behav Genet       Date:  1995-05       Impact factor: 2.805

7.  The impact of gender and age at onset on the familial aggregation of schizophrenia.

Authors:  W Maier; D Lichtermann; J Minges; R Heun; J Hallmayer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

8.  School-associated problem behavior in childhood and adolescence and development of adult schizotypal symptoms: a follow-up of a clinical cohort.

Authors:  Selene Fagel; Leo de Sonneville; Herman van Engeland; Hanna Swaab
Journal:  J Abnorm Child Psychol       Date:  2014

9.  Processing sentence context in women with schizotypal personality disorder: an ERP study.

Authors:  Margaret A Niznikiewicz; Michelle Friedman; Martha E Shenton; Martina Voglmaier; Paul G Nestor; Melissa Frumin; Larry Seidman; John Sutton; Robert W McCarley
Journal:  Psychophysiology       Date:  2004-05       Impact factor: 4.016

10.  Development of schizotypal symptoms following psychiatric disorders in childhood or adolescence.

Authors:  Selene S A A Fagel; Hanna Swaab; Leo M J De Sonneville; Sophie Van Rijn; Jolijn K Pieterse; Floor Scheepers; Herman Van Engeland
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-04-07       Impact factor: 4.785

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.